486 related articles for article (PubMed ID: 33089648)
41. COVID-19 in elderly kidney transplant recipients.
Crespo M; Pérez-Sáez MJ; Redondo-Pachón D; Llinàs-Mallol L; Montero MM; Villar-García J; Arias-Cabrales C; Buxeda A; Burballa C; Vázquez S; López T; Moreno F; Mir M; Outón S; Sierra A; Collado S; Barrios C; Rodríguez E; Sans L; Barbosa F; Cao H; Arenas MD; Güerri-Fernández R; Horcajada JP; Pascual J
Am J Transplant; 2020 Oct; 20(10):2883-2889. PubMed ID: 32471001
[TBL] [Abstract][Full Text] [Related]
42. Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: A retrospective study in two designated hospitals in Anhui, China.
Zuo Y; Liu Y; Zhong Q; Zhang K; Xu Y; Wang Z
J Med Virol; 2020 Nov; 92(11):2666-2674. PubMed ID: 32492211
[TBL] [Abstract][Full Text] [Related]
43. The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment.
Çınarka H; Günlüoğlu G; Çörtük M; Yurt S; Kıyık M; Koşar F; Tanrıverdi E; Arslan MA; Baydili KN; Koç AS; Altın S; Çetinkaya E
Turk J Med Sci; 2021 Aug; 51(4):1624-1630. PubMed ID: 33726482
[TBL] [Abstract][Full Text] [Related]
44. Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019.
Yu M; Wang DC; Li S; Lei YH; Wei J; Huang LY
J Med Virol; 2022 Apr; 94(4):1513-1522. PubMed ID: 34837230
[TBL] [Abstract][Full Text] [Related]
45. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.
Demir E; Uyar M; Parmaksiz E; Sinangil A; Yelken B; Dirim AB; Merhametsiz O; Yadigar S; Atan Ucar Z; Ucar AR; Demir ME; Mese M; Akin EB; Garayeva N; Safak S; Oto OA; Yazici H; Turkmen A
Transpl Infect Dis; 2020 Oct; 22(5):e13371. PubMed ID: 32657540
[TBL] [Abstract][Full Text] [Related]
46. Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study.
Estella Á; Garcia Garmendia JL; de la Fuente C; Machado Casas JF; Yuste ME; Amaya Villar R; Estecha MA; Yaguez Mateos L; Cantón Bulnes ML; Loza A; Mora J; Fernández Ruiz L; Díez Del Corral Fernández B; Rojas Amezcua M; Rodriguez Higueras MI; Díaz Torres I; Recuerda Núñez M; Zaheri Beryanaki M; Rivera Espinar F; Matallana Zapata DF; Moreno Cano SG; Gimenez Beltrán B; Muñoz N; Sainz de Baranda Piñero A; Bustelo Bueno P; Moreno Barriga E; Rios Toro JJ; Pérez Ruiz M; Gómez González C; Breval Flores A; de San José Bermejo Gómez A; Ruiz Cabello Jimenez MA; Guerrero Marín M; Ortega Ordiales A; Tejero-Aranguren J; Rodriguez Mejías C; Gomez de Oña J; de la Hoz C; Ocaña Fernández D; Ibañez Cuadros S; Garnacho Montero J;
Med Intensiva (Engl Ed); 2022 Apr; 46(4):179-191. PubMed ID: 35461665
[TBL] [Abstract][Full Text] [Related]
47. Pneumonia-targeted lopinavir/ritonavir-based treatment for patients with COVID-19: an early-period retrospective single center observational study.
Kim J; Jung J; Kim TH; Kang N; Choi H; Oh DH; Ahn MY; Kim SH; Hahm C; Lee YK; Park K; Hong K; Choi JP
BMC Infect Dis; 2021 Sep; 21(1):952. PubMed ID: 34521365
[TBL] [Abstract][Full Text] [Related]
48. Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics.
Meziyerh S; Zwart TC; van Etten RW; Janson JA; van Gelder T; Alwayn IPJ; de Fijter JW; Reinders MEJ; Moes DJAR; de Vries APJ
Am J Transplant; 2020 Jul; 20(7):1896-1901. PubMed ID: 32337790
[TBL] [Abstract][Full Text] [Related]
49. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
[TBL] [Abstract][Full Text] [Related]
50. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.
Barrasa H; Rello J; Tejada S; Martín A; Balziskueta G; Vinuesa C; Fernández-Miret B; Villagra A; Vallejo A; San Sebastián A; Cabañes S; Iribarren S; Fonseca F; Maynar J;
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):553-561. PubMed ID: 32278670
[TBL] [Abstract][Full Text] [Related]
51. COVID-19 in kidney transplant recipients.
Gandolfini I; Delsante M; Fiaccadori E; Zaza G; Manenti L; Degli Antoni A; Peruzzi L; Riella LV; Cravedi P; Maggiore U
Am J Transplant; 2020 Jul; 20(7):1941-1943. PubMed ID: 32233067
[No Abstract] [Full Text] [Related]
52. COVID-19 in Lung Transplant Recipients.
Messika J; Eloy P; Roux A; Hirschi S; Nieves A; Le Pavec J; Sénéchal A; Saint Raymond C; Carlier N; Demant X; Le Borgne A; Tissot A; Debray MP; Beaumont L; Renaud-Picard B; Reynaud-Gaubert M; Mornex JF; Falque L; Boussaud V; Jougon J; Mussot S; Mal H;
Transplantation; 2021 Jan; 105(1):177-186. PubMed ID: 33141808
[TBL] [Abstract][Full Text] [Related]
53. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.
Berenguer J; Ryan P; Rodríguez-Baño J; Jarrín I; Carratalà J; Pachón J; Yllescas M; Arriba JR; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Clin Microbiol Infect; 2020 Nov; 26(11):1525-1536. PubMed ID: 32758659
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review.
Joseph BA; Dibas M; Evanson KW; Paranjape G; Vegivinti CTR; Selvan PT; Saravu K; Gupta N; Pulakurthi YS; Keesari PR; Varsha S; Chittajallu S; Dmytriw AA; Reierson NL; Mikoff N; Kamrowski S; Schmidt M; Davis AR; Pederson JM; Mishra HK; Touchette JC; Kallmes K
Expert Rev Anti Infect Ther; 2021 Jun; 19(6):679-687. PubMed ID: 33187459
[No Abstract] [Full Text] [Related]
55. Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra.
Mortaz E; Bassir A; Dalil Roofchayee N; Dezfuli NK; Jamaati H; Tabarsi P; Moniri A; Rezaei M; Mehrian P; Varahram M; Marjani M; Mumby S; Adcock IM
Int Immunopharmacol; 2021 Apr; 93():107407. PubMed ID: 33631512
[TBL] [Abstract][Full Text] [Related]
56. Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?
Rodriguez-Cubillo B; de la Higuera MAM; Lucena R; Franci EV; Hurtado M; Romero NC; Moreno AR; Valencia D; Velo M; Fornie IS; Sanchez-Fructuoso AI
Am J Transplant; 2020 Nov; 20(11):3173-3181. PubMed ID: 32529737
[TBL] [Abstract][Full Text] [Related]
57. Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.
Salto-Alejandre S; Jiménez-Jorge S; Sabé N; Ramos-Martínez A; Linares L; Valerio M; Martín-Dávila P; Fernández-Ruiz M; Fariñas MC; Blanes-Juliá M; Vidal E; Palacios-Baena ZR; Hernández-Gallego R; Carratalá J; Calderón-Parra J; Ángeles Marcos M; Muñoz P; Fortún-Abete J; Aguado JM; Arnaiz-Revillas F; Blanes-Hernández R; de la Torre-Cisneros J; López-Cortés LE; García de Vinuesa-Calvo E; Rosso CM; Pachón J; Sánchez-Céspedes J; Cordero E;
PLoS One; 2021; 16(4):e0250796. PubMed ID: 33914803
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Hassaniazad M; Bazram A; Hassanipour S; Fathalipour M
Trials; 2020 Oct; 21(1):886. PubMed ID: 33109246
[TBL] [Abstract][Full Text] [Related]
59. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Ader F; Peiffer-Smadja N; Poissy J; Bouscambert-Duchamp M; Belhadi D; Diallo A; Delmas C; Saillard J; Dechanet A; Mercier N; Dupont A; Alfaiate T; Lescure FX; Raffi F; Goehringer F; Kimmoun A; Jaureguiberry S; Reignier J; Nseir S; Danion F; Clere-Jehl R; Bouiller K; Navellou JC; Tolsma V; Cabié A; Dubost C; Courjon J; Leroy S; Mootien J; Gaci R; Mourvillier B; Faure E; Pourcher V; Gallien S; Launay O; Lacombe K; Lanoix JP; Makinson A; Martin-Blondel G; Bouadma L; Botelho-Nevers E; Gagneux-Brunon A; Epaulard O; Piroth L; Wallet F; Richard JC; Reuter J; Staub T; Lina B; Noret M; Andrejak C; Lê MP; Peytavin G; Hites M; Costagliola D; Yazdanpanah Y; Burdet C; Mentré F;
Clin Microbiol Infect; 2021 Dec; 27(12):1826-1837. PubMed ID: 34048876
[TBL] [Abstract][Full Text] [Related]
60. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study.
Favà A; Cucchiari D; Montero N; Toapanta N; Centellas FJ; Vila-Santandreu A; Coloma A; Meneghini M; Manonelles A; Sellarés J; Torres I; Gelpi R; Lorenzo I; Ventura-Aguiar P; Cofan F; Torregrosa JV; Perelló M; Facundo C; Seron D; Oppenheimer F; Bestard O; Cruzado JM; Moreso F; Melilli E
Am J Transplant; 2020 Nov; 20(11):3030-3041. PubMed ID: 32777153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
